Ion Exchange (500214) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
20 Aug, 2026Executive summary
Consolidated operating income for Q1 FY26 was INR 5,832 million, up 2.7% year-on-year, with net profit rising 8% to INR 484 million and a PAT margin of 8.3%.
Unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, were approved by the Board and reviewed by independent auditors with no material misstatements.
Pioneer in water, wastewater treatment, and environment solutions with global presence and diversified product portfolio.
Operates 7 manufacturing and assembly facilities in India and several abroad, serving industrial, institutional, and consumer clients.
FY25 consolidated revenue mix: Engineering 61%, Chemicals 29%, Consumer Products 10%.
Financial highlights
Q1 FY26 consolidated EBITDA was INR 627 million, down 2.2% year-on-year; EBITDA margin at 10.75%.
Diluted EPS for Q1 FY26 at INR 4.108, up 8.3% year-on-year.
Standalone revenue from operations was ₹51,783 lacs, up slightly year-over-year; consolidated revenue was ₹58,319 lacs, up from ₹56,757 lacs.
Standalone profit after tax was ₹4,688 lacs; consolidated profit after tax was ₹4,844 lacs, both up year-over-year.
Sequentially, operating income declined 30.1% and net profit declined 20.1% from Q4 FY25.
Outlook and guidance
Greenfield resin manufacturing plant at Roha on track for commissioning in Q2 FY26, expected to drive export and domestic growth.
No major change in outlook versus previous quarter; full-year guidance to be updated after Q2.
Operations stabilized after SAP migration, which had temporarily affected business volumes.
Management does not envisage any liability regarding the ongoing SEBI matter with the subsidiary IEEFL.
Latest events from Ion Exchange
- Global leader in water solutions with strong growth, innovation, and expanding service reach.500214
Investor presentation - Revenue up 20% YoY, but margins and profit down; order book and strategy support future growth.500214
Q1 26/27 - Q1 FY25 delivered double-digit revenue and profit growth, with strong segment performance.500214
Q1 24/25 - Strong revenue and profit growth in Q2/H1 FY25; future outlook robust despite key risks.500214
Q2 24/25 - Strong revenue and profit growth, led by Engineering and Chemicals, despite margin pressures.500214
Q3 24/25 - Revenue and profit rose year-over-year, with a ₹1.50 dividend and robust segment growth.500214
Q4 24/25 - Revenue up, margins pressured; Roha plant, new orders, and SEBI litigation shape outlook.500214
Q2 25/26 - Revenue up, margins and profits down due to costs and Labour Codes; SEBI case ongoing.500214
Q3 25/26 - FY26 revenue rose 6.5% but net profit fell on margin pressure and legal, regulatory risks.500214
Q4 25/26